Top Story

Microvascular disease increases risk for CV events in type 2 diabetes

May 24, 2016

In adults with type 2 diabetes free of cardiovascular disease, the burden of microvascular disease confers a risk for future cardiovascular events similar to the risks observed from smoking, hypertension and dyslipidemia, according to recent study findings.

“The risk of a first [CV] event increased linearly with the number of manifestations of microvascular disease present,” Jack R.W. Brownrigg, MRCS, of St. George’s Vascular Institute and St. George’s University of London, and colleagues wrote. “Furthermore, the presence of isolated retinopathy, peripheral neuropathy or nephropathy confers at least a similar risk for [CV] events as risk factors contained in contemporary risk equations, such as blood pressure, LDL cholesterol and HbA1c.”

Business of Endocrinology

Barking up the wrong tree: More on drug pricing

Endocrine Today, May 2016
Richard O. Dolinar, MD
A bill currently before the Massachusetts Senate, S.1048, would require pharmaceutical companies to release information about the cost of the development and production…
Imaging Analysis

Incidental finding leads to parathyroid adenoma discovery

Endocrine Today, May 2016
Poorani Goundan, MBBS; Stephanie L. Lee, MD PhD ECNU
A 52-year-old woman with type 2 diabetes and hypertension was found to have hypercalcemia incidentally on routine blood testing. She did not have family history of…

Resolve ADHD to improve diabetes self-management

Endocrine Today, May 2016
Eliot LeBow, LCSW CDE
Many people with type 1 diabetes also live with attention-deficit/hyperactivity disorder. When they imagine ADHD, most people think of a child who can’t sit still…
Cover Story

Prediabetes intervention, education key to diabetes prevention

Endocrine Today, May 2016
Approximately 86 million Americans — about one in three — are estimated to have a blood glucose level that is higher than normal, but not high enough for a…
More News Headlines »
CME Video

Secondary Prevention of Atherothrombotic Events: Current Insights on Advancing Science

This activity is supported by an educational grant from Merck & Co.

Prevention of cardiovascular disease (CVD) is critical in light of its associated mortality, morbidity, and economic…
More »
Meeting News Coverage

VIDEO: PEGASUS-TIMI 54 analysis shows reduced risk for MACE in patients with diabetes

April 7, 2016
More »
Highlights from ENDO 2016

Highlights from ENDO 2016


Diabetic Retinopathy: The Importance of Early Screening, Referral, and Management

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic eye disease is one of the most common causes of vision loss in the United States. As the rates of diabetes…
More »
Current Issues
View the Current Issues